ASP Isotopes (NASDAQ:ASPI) vs. AdvanSix (NYSE:ASIX) Critical Review

AdvanSix (NYSE:ASIX) and ASP Isotopes (NASDAQ:ASPI) are both small-cap materials companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Earnings and Valuation

This table compares AdvanSix and ASP Isotopes”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdvanSix	$1.52 billion	0.36	$49.29 million	$0.37	54.19
ASP Isotopes	$26.93 million	23.34	-$175.09 million	($2.08)	-1.97

AdvanSix has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares AdvanSix and ASP Isotopes’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AdvanSix	0.67%	2.18%	1.05%
ASP Isotopes	-644.40%	-112.46%	-53.36%

Insider & Institutional Ownership

86.4% of AdvanSix shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 5.0% of AdvanSix shares are owned by company insiders. Comparatively, 14.4% of ASP Isotopes shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk and Volatility

AdvanSix has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.61, suggesting that its share price is 261% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for AdvanSix and ASP Isotopes, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdvanSix	1	2	0	0	1.67
ASP Isotopes	1	0	2	0	2.33

AdvanSix presently has a consensus target price of $22.50, indicating a potential upside of 12.21%. ASP Isotopes has a consensus target price of $13.00, indicating a potential upside of 217.07%. Given ASP Isotopes’ stronger consensus rating and higher possible upside, analysts clearly believe ASP Isotopes is more favorable than AdvanSix.

Summary

AdvanSix beats ASP Isotopes on 8 of the 14 factors compared between the two stocks.

About AdvanSix

AdvanSix Inc. engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capran, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.